Is Utilitywise PLC Is Better Pick Than Centrica PLC And SSE PLC?

Should you avoid Centrica PLC (LON: CNA) and SSE PLC (LON: SSE) but buy Utilitywise PLC (LON: UTW)?

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Centrica (LSE: CNA) and SSE (LSE: SSE) are two of the UK’s largest utility companies while Utilitywise (LSE: UTW) is an industry upstart that’s growing rapidly. 

Indeed, City analysts expect Utilitywise to report earnings per share growth of 18% for full-year 2015, followed by growth of 40% during 2016. But forecasts suggest that Centrica’s earnings per share are set to fall 7% this year, before rising 1% during 2016, whilst SSE’s earnings are projected to fall by 11% for the full year 2015. 

Nevertheless, when it comes to dividends, SSE and Centrica are unbeatable. For example, SSE’s shares currently support a dividend yield of 5.8% and Centrica’s shares currently yield 5.6%. Both payouts are covered one-and-a-half times by earnings per share. 

Dividend champions 

As a reliable dividend-paying stocks, you can’t do much better than SSE and Centrica.

Due to the nature of their businesses, the two companies have a certain degree of clarity over revenue streams. As a result, it is unlikely management will suddenly take an axe to the dividend. That being said, Centrica did announce a dividend cut earlier this year, but many analysts were expecting the company to make such a move after Centrica’s misguided expansion into the oil & gas market. 

Now, Centrica’s dividend payout looks safe for the time being. Payout cover has increased by 30% since the beginning of the year, and the company is curtailing its exposure to the volatile oil & gas market. 

Still, SSE and Centrica aren’t going to make you a millionaire overnight. Although, the two companies are steady, defensive bets that should have a place in any investor’s portfolio as a backbone from which to build the rest of the portfolio around. 

Complex accounting

Utilitywise is a growth play that’s only suitable for investors who are willing to take on the extra risk. But while Utilitywise has the backing of the City’s star fund manager Neil Woodford, I’m not convinced the company has a bright future. 

It is Utilitywise’s aggressive accounting methods that concern me. Utilitywise is booking revenue up to three years in advance, assuming that its customers will remain with the company and extend contracts for the duration of the period. 

As Utilitywise’s targeted customer is the small-and-medium-sized enterprise, this is an especially risky strategy. Around 10% of the business in the UK “die” every year, which indicates that a number of Utilitywise’s customers will go out of business at some point during their three-year contract. Utilitywise will, at some point, be faced with writedowns on the value of already booked revenue. Chasing revenue growth through aggressive accounting over sustainable quality growth is never a good idea.

On the other hand, both Centrica and SSE are stable businesses, with massive, diversified customer bases that aren’t using aggressive accounting techniques to book revenue. Moreover, Utilitywise won’t appeal to income investors as the company’s shares only offer a yield of 2%.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Rupert Hargreaves has no position in any shares mentioned. The Motley Fool UK has recommended Centrica. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Despite rising 152% in a year, is Rolls-Royce’s share price still a bargain?

While Rolls-Royce’s share price has shot up recently, it still looks very undervalued against its peers, and the business looks…

Read more »

Investing Articles

Could Nvidia stock be a bargain in plain sight?

Nvidia stock has surged 252% over the past 12 months, but that doesn't mean it's expensive. In fact, it may…

Read more »

Investing Articles

Here’s why I think the Vodafone share price should be 110% higher

Reflecting on speculation, our writer believes there’s a case to be made for the Vodafone share price being more than…

Read more »

A pastel colored growing graph with rising rocket.
Investing Articles

Is this dividend star also the best bargain in the FTSE 100?

This FTSE 100 stock pays a whopping 8%+ yield, looks very undervalued against its peers, and is set for stellar…

Read more »

Investing Articles

2 FTSE 100 stocks. One sublime, the other ridiculous

Our writer doesn’t understand the appeal of Ocado. But looking at the grocer’s latest results makes him see the attraction…

Read more »

Portrait of elderly man wearing white denim shirt and glasses looking up with hand on chin. Thoughtful senior entrepreneur, studio shot against grey background.
Investing Articles

Down 18% in a year, what’s next for the Greatland Gold (GGP) share price?

The Greatland Gold share price has disappointed over the past 12 months. Our writer asks whether the company’s latest update…

Read more »

Investor looking at stock graph on a tablet with their finger hovering over the Buy button
Investing Articles

With 30% annual returns for a decade, I’m buying this for my Stocks & Shares ISA

Oliver Rodzianko has been looking for a new investment for his Stocks and Shares ISA. Here's one he's decided is…

Read more »

Investing Articles

These were the FTSE 100’s dogs and stars in February

The FTSE 100 limped along last month, but some Footsie shares soared while others slumped. Here are February's winners and…

Read more »